MedTrace Logo

Laparoscopy for Primary Cytoreductive Surgery in Advanced Ovarian Cancer

NCT02980185 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2016-12-02

No results posted yet for this study

Summary

To assess the feasibility, Residual Tumor, complication rate and survival of totally laparoscopic primary cytoreduction in carefully selected patients with Advanced Ovarian Cancer, compared with abdominal primary cytoreduction in a single-Institution, single-surgeon prospective series.

Conditions

  • Residual Tumor
  • Disease-free Survival
  • Overall Survival

Interventions

PROCEDURE

Laparoscopic primary cytoreduction

Primary cytoreduction for ovarian cancer performed through a completely minimally-invasive approach

Sponsors & Collaborators

  • Università degli Studi dell'Insubria

    lead OTHER

Principal Investigators

  • Stefano Uccella, MD, PhD · Università degli Studi dell'Insubria

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2015-07-31
Completion
2016-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02980185 on ClinicalTrials.gov